PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
SNEX vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

SNEX vs. XBI

Last updated Aug 6, 2026
Documentation

SNEX (StoneX Group Inc.) is a stock, while XBI (SPDR S&P Biotech ETF) is Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Over the past 10 years, SNEX returned 28.44%/yr vs 9.23%/yr for XBI. Their 0.33 correlation means their historical movements had little consistent relationship.

Performance

SNEX vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in StoneX Group Inc. (SNEX) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SNEX achieves a 79.80% return, which is significantly higher than XBI's 25.61% return. Over the past 10 years, SNEX has outperformed XBI with an annualized return of 28.44%, while XBI has yielded a comparatively lower 9.23% annualized return.

SNEX

1D
1.05%
1M
-6.75%
6M
45.73%
YTD
79.80%
1Y
76.41%
3Y*
57.80%
5Y*
41.94%
10Y*
28.44%
ALL TIME*
17.00%

XBI

1D
0.74%
1M
-4.85%
6M
22.24%
YTD
25.61%
1Y
76.98%
3Y*
23.76%
5Y*
3.88%
10Y*
9.23%
ALL TIME*
11.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)

SNEX

StoneX Group Inc.
$68.15M$81.76M$100.95M

XBI

SPDR S&P Biotech ETF
$1.20B$1.32B$1.30B

SNEX vs. XBI - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
SNEX
StoneX Group Inc.		79.80%45.65%32.70%16.21%55.59%5.79%18.57%33.49%-13.99%7.40%
XBI
SPDR S&P Biotech ETF		25.61%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Correlation

The correlation between SNEX and XBI is 0.26, which is low. Their historical price movements had little consistent relationship.

Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.26

Correlation (3Y)
Balances recent behavior with more history.

0.32

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.33

Correlation (10Y)
Provides a long-term view across more market conditions.

0.32

Correlation (All Time)
Calculated using the full available price history since Feb 6, 2006

0.33

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

StoneX Group Inc.

SPDR S&P Biotech ETF

Often compared with SNEX:
SNEX vs. QQQSNEX vs. MAINSNEX vs. CCAPSNEX vs. GAINSNEX vs. FASTSNEX vs. ^GSPCSNEX vs. BIZD
Often compared with XBI:
XBI vs. IBBXBI vs. ARKGXBI vs. LABUXBI vs. BBHXBI vs. VOOXBI vs. IBBQXBI vs. FBIOX

Return for Risk

SNEX vs. XBI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.
SNEX
SNEX Risk / Return Rank: 8484
Overall Rank
SNEX Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
SNEX Sortino Ratio Rank: 7979
Sortino Ratio Rank
SNEX Omega Ratio Rank: 8383
Omega Ratio Rank
SNEX Calmar Ratio Rank: 8686
Calmar Ratio Rank
SNEX Martin Ratio Rank: 8686
Martin Ratio Rank
XBI
XBI Risk / Return Rank: 9393
Overall Rank
XBI Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 9292
Sortino Ratio Rank
XBI Omega Ratio Rank: 8989
Omega Ratio Rank
XBI Calmar Ratio Rank: 9797
Calmar Ratio Rank
XBI Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SNEX vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for StoneX Group Inc. (SNEX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

SNEXXBIDifference
Sharpe ratioReturn per unit of total volatility
1.62
2.86

-1.24

Sortino ratioReturn per unit of downside risk
2.04
3.66

-1.62

Omega ratioGain probability vs. loss probability

1.30

1.44

-0.14

Calmar ratioReturn relative to maximum drawdown

2.96

7.36

-4.40

Martin ratioReturn relative to average drawdown

7.78

20.17

-12.40

SNEX vs. XBI - Sharpe Ratio Comparison

The current SNEX Sharpe Ratio is 1.62, which is lower than the XBI Sharpe Ratio of 2.86. The chart below compares the historical Sharpe Ratios of SNEX and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

SNEX vs. XBI - Drawdown Comparison

The maximum SNEX drawdown since its inception was -97.89%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SNEX and XBI.

Loading charts...

Drawdown Indicators

SNEXXBIDifference

Max Drawdown

Largest peak-to-trough decline

-97.89%

-63.89%

-34.00%

Max Drawdown (1Y)

Largest decline over 1 year

-25.91%

-10.51%

-15.40%

Max Drawdown (3Y)

Largest decline over 3 years

-25.91%

-32.99%

+7.08%

Max Drawdown (5Y)

Largest decline over 5 years

-25.91%

-54.00%

+28.09%

Max Drawdown (10Y)

Largest decline over 10 years

-48.65%

-63.89%

+15.24%

Current Drawdown

Current decline from peak

-17.97%

-11.48%

-6.49%

Average Drawdown

Average peak-to-trough decline

-42.75%

-20.87%

-21.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.98%

3.83%

+6.15%

Volatility

SNEX vs. XBI - Volatility Comparison

StoneX Group Inc. (SNEX) has a higher volatility of 15.68% compared to SPDR S&P Biotech ETF (XBI) at 8.26%. This indicates that SNEX's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

SNEXXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.68%

8.26%

+7.42%

Volatility (6M)

Calculated over the trailing 6-month period

37.23%

21.56%

+15.67%

Volatility (1Y)

Calculated over the trailing 1-year period

47.45%

27.11%

+20.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.45%

32.32%

+4.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.03%

31.94%

+5.09%

Dividends

SNEX vs. XBI - Dividend Comparison

SNEX has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.37%.

PositionTTM20252024202320222021202020192018201720162015
SNEX
StoneX Group Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF		0.37%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions

SNEX and XBI have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SNEX has higher volatility (15.68%) compared to XBI (8.26%). In terms of maximum drawdown, SNEX dropped -97.89% vs XBI's -63.89%.

XBI currently has the higher Sharpe Ratio (2.86 vs 1.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SNEX and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer